摘要
背景:铁是细菌,真菌和人类必需的微量营养素,因此,每个人都进化出专门的铁摄取系统以从细胞外环境获取铁。 目的:描述在这一重要营养素的争夺战中人类宿主与病原微生物之间进化出来的铁的复杂“拔河”。 方法:回顾当前的文献进行评估目前的方法和铁在人类中的治疗和螯合的争议。 结果:在人体中,从入侵病原体中螯合(隐藏)铁通常是成功的;然而,许多病原体已经发展出机制来绕过这种方法。 结论:在临床上,铁超负荷或铁给药是否会导致感染风险增加,争议仍在继续。将铁螯合剂和铁载体缀合物药物给予感染的宿主似乎是一种生物合理的方法,作为辅助治疗由依赖于宿主铁供应的病原体(例如结核,疟疾和许多细菌和真菌病原体)引起的感染的辅助治疗;然而,迄今为止,在人类的研究证明是不成功的。
关键词: 感染,铁,营养免疫,铁载体,铁超载,铁螯合。
Current Medicinal Chemistry
Title:The Battle for Iron between Humans and Microbes
Volume: 25 Issue: 1
关键词: 感染,铁,营养免疫,铁载体,铁超载,铁螯合。
摘要: Background: Iron is an essential micronutrient for bacteria, fungi, and humans; as such, each has evolved specialized iron uptake systems to acquire iron from the extracellular environment.
Objective: To describe complex ‘tug of war’ for iron that has evolved between human hosts and pathogenic microorganisms in the battle for this vital nutrient.
Methods: A review of current literature was performed, to assess current approaches and controversies in iron therapy and chelation in humans.
Results: In humans, sequestration (hiding) of iron from invading pathogens is often successful; however, many pathogens have evolved mechanisms to circumvent this approach.
Conclusion: Clinically, controversy continues whether iron overload or administration of iron results in an increased risk of infection. The administration of iron chelating agents and siderophore- conjugate drugs to infected hosts seems a biologically plausible approach as adjunctive therapy in the treatment of infections caused by pathogens dependent on host iron supply (e.g. tuberculosis, malaria, and many bacterial and fungal pathogens); however, thus far, studies in humans have proved unsuccessful.
Export Options
About this article
Cite this article as:
The Battle for Iron between Humans and Microbes, Current Medicinal Chemistry 2018; 25 (1) . https://dx.doi.org/10.2174/0929867324666170720110049
DOI https://dx.doi.org/10.2174/0929867324666170720110049 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The CD4C/HIVNef Transgenic Model of AIDS
Current HIV Research Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Current Diabetes Reviews Capacity Building in Genomics Medicine and Molecular Diagnostics: The Case of Sri Lanka
Current Pharmacogenomics and Personalized Medicine Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
Infectious Disorders - Drug Targets Antitubercular Properties of Substituted Hydroxycyclohexadienones
Letters in Drug Design & Discovery Malaria and artemisinin derivatives: an updated review
Mini-Reviews in Medicinal Chemistry Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study
Current Radiopharmaceuticals Bacterial Protein Microarrays for Diagnosis of Infectious Diseases
Current Immunology Reviews (Discontinued) Exploiting Innate γδ T Lymphocytes for Tumor Immunotherapy
Recent Patents on Biomarkers Polymorphic Receptors of the Innate Immune System (MBL/MASP-2 and TLR2/4) and Susceptibility to Pneumococcal Bacteremia in HIV-Infected Patients: A Case-Control Study
Current HIV Research Tuberculosis and its Treatment: An Overview
Mini-Reviews in Medicinal Chemistry Synthesis of Substituted -N-(5-((7-Methyl-2-Oxo-2H-Chromen-4-yl)- Methyl)-1,3,4-Thiadiazol-2-yl)-Benzamide Derivatives Using TBTU as Coupling Agent and their Evaluation for Anti Tubercular Activity
Letters in Organic Chemistry Phytochemistry, Antinociceptive and Anti-inflammatory Actvities of Methanolic Leaves Extract of Lannea schimperi (Hoschst. Ex Rich) ENG.
Recent Patents on Biotechnology Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications
Current Pharmaceutical Design Inflammasome Signaling in Pathogenesis of Lung Diseases
Current Pharmaceutical Design Target Product Selection - Where Can Molecular Pharming Make the Difference?
Current Pharmaceutical Design Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry Phenothiazines as Anti-Multi-Drug Resistant Tubercular Agents
Infectious Disorders - Drug Targets Patent Selections:
Recent Patents on Drug Delivery & Formulation Interethnic and Intraethnic Variability of NAT2 Single Nucleotide Polymorphisms
Current Drug Metabolism